Upregulation of miR‑144‑3p expression attenuates glioma cell viability and invasion by targeting BCL6
Affiliations: Department of Neurosurgery, Nanchang University People's Hospital, Nanchang, Jianxi 330006, P.R. China, Department of Neurosurgery, Peking University People's Hospital, Beijing 100044, P.R. China
- Published online on: August 10, 2021 https://doi.org/10.3892/etm.2021.10591
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Glioma remains to be an aggressive type of cancer with poor prognosis irrespective of the type of standard treatment applied. Therefore, identification of accurate early diagnostic methods and therapeutic strategies for glioma is imperative for the treatment of this disease. The expression of a number of miRNAs in glioma have been reported to be associated with the regulation of tumorigenic progression, cancer cell proliferation, metastasis, invasion, angiogenesis and drug resistance. The aim of the present study was to assess the function of the microRNA (miR/miRNA)‑144‑3p/BCL6 axis in glioma. Reverse transcription‑quantitative PCR was used to measure miR‑144‑3p and BCL6 expression. Western blotting was used for measuring BCL6 expression. Luciferase reporter assay was used to assess the association between miR‑144‑3p and BCL6 and a tumor xenograft model was established for assess tumor growth. The data demonstrated that miR‑144‑3p was decreased whereas BCL6 expression was increased in glioma tissues compared with those in healthy human brain tissues, where miR‑144‑3p suppressed BCL6 expression by targeting the 3'‑UTR sequence of BCL6. miR‑144‑3p overexpression alleviated proliferation and invasion in U251 cells whereas transfection with the BCL6‑overexpressing plasmid rescued the suppressive effects of miR‑144‑3p upregulation on the proliferation and invasion of U251 cells. In addition, miR‑144‑3p overexpression and BCL6 downregulation inhibited tumor progression in a mouse tumor xenograft model. The present findings suggest that miR‑144‑3p and BCL6 may serve to be indicator of proliferation and invasion for patients with glioma. Furthermore, BCL6 may serve an important role in the miR‑144‑3p‑mediated regulation of proliferation and invasion of glioma cells, where the miR‑144‑3p/BCL6 axis can be used to target patients with glioma therapeutically.